The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Familial malignant melanoma ‐ overview
Open accessAbstract
Approximately 3-15% of all malignant melanomas (MM) are familial cases. MM is a highly heterogeneous tumour type from a genetic perspective. Pedigrees with disease confined to a single generation of siblings or MM occurring among second- or third-degree relatives suggest multifactorial polygenic inheritance. However, not infrequently, within large families aggregations of MM are consistent with autosomal dominant inheritance, suggesting a hereditary syndrome caused by germline alterations of a single gene. Several different genes are involved in the development of MM. However, even when taken together they are responsible for less than 20% of all MM cases. It is thus necessary to perform association studies focused on genetic markers that could be used in identifying patients with a high risk of MM. Evaluation of aggregations of MM and other malignancies, like breast cancer, could be essential in identifying relatives of MM probands being at high risk of developing malignancies other than MM. The ultimate goal is to apply in these cases prevention recommendations and surveillance protocols to reduce the disease risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Approximately 3–15% of melanomas arise due to familial genetic predisposition, in which UV-independent mutations play a significant role17.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“It inhibits the activity of the complex of cyclin D1 with cyclin-dependent kinase 4 (CDK4) or 6 (CDK6), the function of which is to promote cellular proliferation [35].”
BackgroundCancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226 · cited 5×
“The NBS1 protein product, called nibrin (also referred to as p95), is an integral component of hMRE11/hRAD50/NBS1 nuclease complex, acting in a double-strand break repair of human DNA [59].”
BackgroundInfluentialNibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome
Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H., Saar, K., Beckmann, G., Seemanová, E., Cooper, P. R., Nowak, N. J., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81174-5 · Cited by 1,079 · cited 1×
“The NBS1 gene is located on 8q21 (OMIM 602667) [58].”
BackgroundSystematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands
Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A., & Skolnick, M. H. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.21.1600 · Cited by 1,031 · cited 1×
“52 when MM cases were diagnosed under 50 years [11].”
BackgroundValverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999 · cited 1×
“It has been reported that some germline allelic variants of the MC1R gene (Arg151Cys, Arg160Trp, Asp294His) conferred to fair skin/red hair phenotype associated with an increased risk of MM [68-70].”
BackgroundGermline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977 · cited 1×
“CDKN2A In 1994 the first and so far the most significant high-risk MM susceptibility gene, CDKN2A (9p21, OMIM 600160) was identified [33, 34].”
BackgroundAnalysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855 · cited 1×
“CDKN2A In 1994 the first and so far the most significant high-risk MM susceptibility gene, CDKN2A (9p21, OMIM 600160) was identified [33, 34].”
BackgroundGermline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 1×
“Up to now germline CDK4 mutations have been found in 3 families world-wide [36, 53, 54].”
BackgroundChildhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies
Whiteman, D. C., Whiteman, C. A., & Green, A. C. (2001) · Cancer Causes & Control · doi:10.1023/a:1008980919928 · Cited by 633
Research works printed but not linked: 2
- Holman CD, Armstrong BK: Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984,72(2):257–266.
- Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H, Ingvar C: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000, 92: 1260–1266. 10.1093/jnci/92.15.1260 · DOI · Paper page
Cited by
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Kudryavtseva, A. V., Fedorova, M., Zhavoronkov, A. A., Moskalev, A., Zasedatelev, A. S., Dmitriev, A. A., Садритдинова, А. Ф., Karpova, I. Y., Nyushko, K. М., Kalinin, D. V., et al. (2016) · BMC Genetics · doi:10.1186/s12863-016-0459-1 · Cited by 53
Špaková, I., Rabajdová, M., Mičková, H., Graier, W. F., & Mareková, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-89792-2 · Cited by 23
Molecular Skin Cancer Diagnosis
Nataren, N. J., Yamada, M., & Prow, T. W. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.09.008 · Cited by 27
Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
Jasinski‐Bergner, S., Blümke, J., Wickenhauser, C., & Seliger, B. (2021) · Cancers · doi:10.3390/cancers13051167 · Cited by 13
“Concerning the hereditary predisposition, it is known that between 5–10% of melanoma cases are familial [6] and mainly induced by germ line mutations in tumor suppressor genes involved in proliferation control and DNA repair of cells.”
Background
Metadata
- Authors
- Dębniak, T.
- Affiliations
- International Hereditary Cancer Center (PL)
- Corresponding author
- Dębniak, Tadeusz
- ORCID
- Dębniak, Tadeusz
- Venue
- Hereditary Cancer in Clinical Practice
- Published
- 2004-07-19
- Volume
- 2
- Issue
- 3
- Pages
- 123-9
- ISSN
- 1731-2302 (ISSN-L)
- 1897-4287
- PMC
- PMC4392520
- OpenAlex
- W2127888640
- Cited by
- 17
- References
- 79
- Citations by year
- 2026: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 3 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Hereditary Cancer in Clinical Practice (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- hereditary melanoma, polygenic inheritance, autosomal dominant inheritance, germline mutations, genetic susceptibility, genetic markers, breast cancer, familial aggregation, cancer surveillance, cancer prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Familial malignant melanoma ‐ overview. https://app.cochat.ai/papers/10.1186/1897-4287-2-3-123
- The paper
- Dębniak, T. (2004). Familial malignant melanoma ‐ overview. Hereditary Cancer in Clinical Practice. https://doi.org/10.1186/1897-4287-2-3-123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.